epigenetic editing
Tune Therapeutics Secures $175M to Advance Epigenetic Editing into Clinical Trials
Epigenetic editing, gene therapy, Tune Therapeutics, clinical trials, biotech funding
nChroma Bio Emerges from Chroma Medicine and Nvelop Therapeutics Merger, Secures $75 Million to Advance Genetic Medicines
nChroma Bio, Chroma Medicine, Nvelop Therapeutics, Genetic Medicines, Epigenetic Editing, Non-Viral Delivery, Biotechnology, Merger, Financing